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Abstract
Background: Rett syndrome is best known due to its severe and devastating symptoms in the central nervous
system. It is produced by mutations affecting the Mecp2 gene that codes for a transcription factor. Nevertheless,
evidence for MECP2 activity has been reported for tissues other than those of the central nervous system. Patients
affected by Rett presented with intestinal affections whose origin is still not known. We have observed that the
Mecp2-null mice presented with episodes of diarrhea, and decided to study the intestinal phenotype in these mice.
Methods: Mecp2-null mice or bearing the conditional intestinal deletion of MECP2 were used. Morphometirc and
histologic analysis of intestine, and RT-PCR, western blot and immunodetection were perfomed on intestinal
samples of the animals. Electrical parameters of the intestine were determined by Ussing chamber experiments in
freshly isolated colon samples.
Results: First we determined that MECP2 protein is mainly expressed in cells of the lower part of the colonic crypts
and not in the small intestine. The colon of the Mecp2-null mice was shorter than that of the wild-type. Histological
analysis showed that epithelial cells of the surface have abnormal localization of key membrane proteins like ClC-2
and NHE-3 that participate in the electroneutral NaCl absorption; nevertheless, electrogenic secretion and
absorption remain unaltered. We also detected an increase in a proliferation marker in the crypts of the colon
samples of the Mecp2-null mice, but the specific silencing of Mecp2 from intestinal epithelium was not able to
recapitulate the intestinal phenotype of the Mecp2-null mice.
Conclusions: In summary, we showed that the colon is severely affected by Mecp2 silencing in mice. Changes in
colon length and epithelial histology are similar to those observed in colitis. Changes in the localization of proteins
that participate in fluid absorption can explain watery stools, but the exclusive deletion of Mecp2 from the intestine
did not reproduce colon changes observed in the Mecp2-null mice, indicating the participation of other cells in this
phenotype and the complex interaction between different cell types in this disease.
Background
Rett syndrome (RTT) is a devastating neurodevelopmen-
tal disorder affecting mainly girls since their early child-
hood. The major cause of RTT are mutations affecting
the methyl-CpG binding protein 2 (MECP2) coding gene
[1]. MECP2 is a transcription factor with a dual role on
gene expression. It was first described that MECP2 binds
to methylated CpG dinucleotides, and by interacting
with the histone deacetylase complex, compacts the
chromatin and silences gene expression [2]. More
recently, it was described that MECP2 is also able to
induce the expression of some of its target genes, mech-
anism mediated by the interaction with the transcription
factor Creb1 [3].
The most significant efforts to understand alterations
produced by MECP2 deficiency have been concentrated
in neurons and, more recently, in microglia and astro-
cytes [4–6]. Nevertheless, cellular abnormalities affecting
other tissues such as the intestinal tract are unknown.
RTT patients have a high incidence of symptoms affect-
ing the lower section of the gastrointestinal tract like* Correspondence: cflores@cecs.cl
1Centro de Estudios Científicos (CECs), Avenida Arturo Prat 514, 511046
Valdivia, Chile
Full list of author information is available at the end of the article
Molecular and Cellular
Pediatrics
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made.
Millar-Büchner et al. Molecular and Cellular Pediatrics  (2016) 3:37 
DOI 10.1186/s40348-016-0065-3
gastroparesis, chronic constipation, and gastric and
intestinal perforations, mainly [7]. The first report of a
RTT patient affected by colon cancer urges the under-
standing of the impact of MECP2 inactivation on epithe-
lial cell function and intestinal physiology [8].
During the breeding of the Mecp2-null mice in our
animal facility, we observed that these animals presented
episodes of diarrhea at around 2 months of age. There-
fore, we decided to study changes on intestinal physi-
ology and histology as a result of genetic inactivation of
the Mecp2 gene in this RTT mouse model. Our analysis
determined that Mecp2-null mice presented macro-
scopic abnormalities in the colon. Histological observa-
tion of intestinal samples allowed us to determine that
the colon crypts are shorter in length and displayed
altered histology of the surface epithelial cells. Immuno-
histochemical analysis showed that proteins of the elec-
troneutral absorptive machinery were abnormally
expressed in Mecp2-null mice, while electrogenic move-
ment of ions was normal. Increased quantity of prolifer-
ating cells was observed in the colon epithelium of
Mecp2-null mice. We were able to observe Mecp2
expression in epithelial cells from the lower part of the
colon crypts, but the selective Mecp2 knockdown in
intestinal epithelium did not recapitulate the observed
features of the Mecp2-null mice, suggesting a complex
interaction between different tissues expressing Mecp2
that participates in the development of the multisystemic




Mecp2-null colony founders were obtained from The
Jackson Lab stock #003890 in a C57BL/6J:129/SvJ gen-
etic background. Colony founders were outbred with
C57BL/6 wild-type male for at least eight generations.
To generate the conditional KO mice for Mecp2 in the
intestinal epithelium, we bred heterozygous Mecp2
female mice carrying one of the Mecp2 allele flanked by
loxP sites with the male mice carrying the Cre recom-
binase protein coding sequence under the control of
Villin promoter. Animals were obtained from The
Jackson Laboratory (Bar Harbor, ME, USA). The mice
were bred in the C57BL/6J strain for at least eight gener-
ations. All mice were housed in ventilated racks under
specific-pathogen-free conditions at a room temperature
of 20 °C ± 2 °C in a 12/12 h light/dark cycle with food
and water ad libitum. All animal procedures were
reviewed and approved by the local Institutional Animal
Care and Use Committee regulations. The animal facility
of the Centro de Estudios Científicos (CECs) is accre-
dited by AAALAC.
Morphological and histology analysis
Adult mice were sacrificed by cervical dislocation. The
small intestine and colon were removed, and the
distance between the duodenum to ileum and the cecum
to rectum, respectively, were measured. Tissues were
fixed, embedded in paraffin and sliced into 4-μm-thick
sections, followed by staining with hematoxylin and
eosin (HE) or Periodic acid–Schiff (PAS). Digital images
were captured with a light microscope (Olympus, CX31)
attached to a computer using ×40 magnification and re-
corded using the MShot Digital Imaging systems program.
The crypt length in the HE sections was measured (in ≥8
crypts per field) as the distance from the base to the apical
side. The PAS sections were used in two different analysis:
(1) counting PAS-positive cells per crypt, expressed as the
percentage of PAS-positive cells normalized by the total
number of epithelial cells lining the colonic crypt, and (2)
PAS-positive pixels per micrometer, which was deter-
mined, converting the PAS-stained sections to grayscale
and splitting it in the three-color channels (green, red, and
blue). The threshold was adjusted to the green channel,
which has the best contrast, to obtain the PAS-positive
pixels. To normalize our results to the crypt longitude,
three lines of known length (μm) were traced on each
crypt and the PAS-positive pixels determined in this area.
Both procedures were performed using the free software,
ImageJ.
Immunoblotting
To determine protein and gene expression in the intes-
tine, section of the colon and small intestine from 8-
week-old mice were rinsed with PBS and opened at the
mesenteric border, and the epithelium was stripped of
muscle using a glass slide. Tissues were homogenized in
M-Per buffer by sonication using a protocol of 6 cycles
of 10-s pulses at a 100% intensity followed by 10 s of rest
using a QSONICA LLC sonicator (Model Q125, USA).
Homogenates were centrifuged at 20,000×g at 4 °C in an
eppendorf centrifuge (Model 5415R, Germany) for
30 min; the pellet was discarded and the proteins from
the supernatant were quantified by Pierce BCA Protein
Assay Kit (Thermo Scientific). Thirty micrograms of
protein extract prepared in loading buffer was electro-
phoresed in denaturing polyacrylamide 4–12% gels
(SDS-PAGE) in reducing conditions and transferred to
PVDF membranes (Bio-Rad Laboratories, Hercules, CA,
USA). Membranes were blocked in 0.05% non-fat milk
and incubated with primary antibody against Mecp2
(Millipore 1:1000) and beta-actin (Santa Cruz 1:5000)
for 2 h at 37 °C. After five washes for 10 min each in
TBST, membranes were incubated with HRP-conjugated
secondary antibody for 1 h at room temperature and
then washed six times in TBST. The bands for Mecp2
and beta-actin were visualized by chemiluminescence
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Pierce West Femto (Life Technologies) and analyzed by
exposing membranes in a C-Digit® Blot Scanner (Licor
Model 3600, USA).
Real-time qPCR
Ages of mice analyzed are given as days post conception
(d.p.c), where the presence of vaginal plugs was consid-
ered as embryonic 0.5 d.p.c. The birth took place at 19
d.p.c (P0). Pregnant females (15.5 d.p.c and 18.5 d.p.c)
were sacrificed by cervical dislocation. Embryos were
dissected from the uteri and placed in PBS. Immediately
following harvest, the colon was dissected and embed-
ded in fresh Trizol Reagent (Invitrogen, CA, USA) and
stored at −80 °C until RNA extraction. RNA was
reverse-transcribed using the ImPrim-IITM Reverse
Transcription System (Promega) to synthesize single-
stranded complementary DNA (cDNA) at a concentra-
tion of 2 μg/μL. PCR reaction mixtures were prepared
using the KAPA SYBR FASTA qPCR kit. All amplifica-
tion reactions were performed in triplicate using the
Rotor Gene 6200, with a total volume of 10 μL, each re-
action containing 1 μL of diluted cDNA. The real-time
program used consisted in an initial denaturation period
of 10 min at 95 °C followed by 40 cycles at 95 °C for
20 s, 58 °C for 15 s, and 72 °C for 30 s. The results were
analyzed with the Rotor Gene-6000 series software 1.7
(Corbett) and all values were normalized to cyclophilin 1
messenger (RNA) mRNA expression levels. The primers
used were the following: Mecp2 forward 5-CTCCA-




AAAAG-3. Colon samples from adult animals were used
for the quantification of mRNA for the ClC-2 accessory
protein Glial-cam using the following primers forward:
5-GGGAGAAGACCATCAAC T-3 and reverse 5-TGAG
CTCCAGCACAGTGGTT-3.
RT-PCR
PCR reaction mixture was prepared in 20 μL total vol-
ume containing 2 μg of reverse-transcribed cDNA as de-
scribed above. The amplification program consisted in
an initial denaturation period of 10 min at 95 °C
followed by 30 cycles at 95 °C for 20 s, 58 °C for 20 s,
and 72 °C for 30 s. The primers used were the following:
Mecp2e1 forward 5-AACGGGGTAGAAAGCCTG-3
and reverse 5-TGATGGGGTCCTCAGAGC-3 and for
isoform, Mecp2e2 forward: 5-CAGGTCATGGTGATC
AAACG-3 and reverse 5-AGTCCTTTCCCGCTCTT
CTC-3. Cyclophilin 1 was used as loading control using
the same primers described above. Amplicons were
electrophoresed in a 1.5% acrylamide gel containing EtBr
and visualized in an Ultraviolet GelDoc-it UVP Transilu-
minator photodocumenter.
Immunohistochemistry
Colonic tissue was isolated and washed in phosphate
buffer saline (PBS). Immunohistochemistry was per-
formed as previously described [9]). Briefly, 4 mM paraf-
fin sections were incubated with the corresponding
primary antibody: ClC-2 1:400 (ACL-002, Alomone),
NHE-3 1:1000 (C-20, Santa Cruz), and NKCC1 1:4000
(kindly provided by R. James Turner, [10]). To detect
bound antibodies, we used the LSAB Universal Kit
(Dako). The positive reaction was developed with diami-
nobenzidine or Vector SG (Vector Labs) and sections
were counterstained with hematoxylin or nuclear fast
red (Vector Labs).
For double immunohistochemistry, samples were first
incubated with anti-ClC2 antibody, and peroxidase activ-
ity was visualized using Vector SG (Vector Labs). At the
end of the first labeling reaction, sections were washed
in 50 mM Tris HCl pH 7.8 and treated as described
above for NHE3 immunolabeling. The counterstaining
was performed with nuclear fast red (Vector Labs).
Immunofluorescence
Colonic and small intestine paraffin-embedded sections
(4 μm) were dewaxed and hydrated before the immuno-
fluorescence procedure. Microwave antigen retrieval was
performed in a 10-mM citrate pH 6. To permeabilize,
the samples were incubated for 30 min with Triton 0.2%
diluted in BSA 5% plus normal goat serum (NGS) 2.5%.
Then, sections were incubated with anti-rabbit MECP2
antibody (1:100, Millipore) at room temperature for 2 h,
washed with 50 mM Tris HCl pH 7.8, and incubated
with secondary antibody Goat anti-Rabbit Alexa Fluor
488 (Life Technologies) for 30 min. The reaction was
visualized in confocal microscopy (Olympus, BX61WI)
and attached to Olympus Flouview FV 1000 software.
Ussing chamber experiments
Experiments were performed as previously described
[11]. Briefly, stripped colonic epithelium was placed in
P2303 tissue holders of 0.1 cm2 surface and placed in
modified Ussing chambers (Physiologic Instruments Inc.,
San Diego, CA, USA) bathed with bicarbonate-buffered
solution (pH 7.4), gassed with 5% CO2–95% O2, and
maintained throughout the experiment at 37 °C. The
transepithelial potential difference referred to the serosal
side was measured using a VCCMC2 amplifier (Physiologic
Instruments Inc., San Diego, CA, USA). Current was
clamped to 0 μA and 200 ms pulses of ±10 μA and was
passed across the tissues at 1 s intervals using the Acquire
& Analyze 2.3v software and a DI-720 interface (DataQ
instruments, Akron, OH, USA).
Millar-Büchner et al. Molecular and Cellular Pediatrics  (2016) 3:37 Page 3 of 10
Plasmatic sodium
Blood was collected by retro-orbital plexus puncture
from 60–62 days old animals. Sodium was determined
using the EasyLyte analyzer (Medica Corporation,
Bedford, MA, USA) under manufacturer’s instructions.
Results
Mecp2 is expressed in colonic epithelium
Immunodetection of Mecp2 was performed in intestinal
tissue of the mice. As shown in Fig. 1a Mecp2 was de-
tected in both the colon and small intestine. Nevertheless,
fractions of smooth muscle and epithelium demonstrate
that Mecp2 is more abundant in the colon than in small in-
testine epithelium. To further determine tissue distribution
of Mecp2, we performed immunofluorescense detection.
Mecp2-positive cells were found mostly at the base of the
colonic crypts (Fig. 1b), while no staining was detected in
small intestine samples (Fig. 1e). The observed immunore-
activity was specific as no reaction was observed in colon
samples from Mecp2-null mice (Fig. 1c) or wild-type mice
when the primary antibody was omitted (Fig. 1d).
To determine which Mecp2 variants are expressed in
the colon epithelium, we performed PCR detection of
Mecp2-E1 and Mecp2-E2. As shown in Fig. 1F, colon
tissue expressed both variants, but when compared to
hypothalamus expression, colon tissues preferentially
expressed Mecp2-E2 (Fig. 1g). Finally, real-time PCR ex-
periments showed that Mecp2 was highly expressed at
the end of fetal development, changing expression levels
with time, decreasing after birth and increasing almost 2
times after weaning (day 21), and maintaining relatively
high levels of expression up to 60 days of age (Fig. 1h).
The Mecp2-null mice exhibit altered colon morphology
and histology
Observation of intestinal anatomical features of 8 weeks
old Mecp2-null mice suggested changes in colon size
(Fig. 2a). Measurement of intestine sections showed that
Fig. 1 Protein and mRNA expression of Mecp2 in mouse intestine. a Representative western blot of Mecp2 from samples obtained from smooth
muscle (SM) or epithelium (E) of the small intestine or colon of wild-type mice (n = 5). Mecp2 detection by immunofluorescence in b colon of
wild-type, c colon of Mecp2-null mice, d colon of wild-type with omitted primary antibody, and e small intestine of wild-type mouse (n = 3 per group).
f RT-PCR detection of Mecp2 variants E1 and E2 in colon epithelium. Lanes 1–3 colon samples, lane 4 RT-negative control, lane 5 hypothalamus sample
from a wild-type mouse, and lane 6 hypothalamus sample from a Mecp2-null mouse. g Relative expression of Mecp2 variants on colon epithelium
measured from the blots showed in f (n = 3). h qPCR from colon of embryonic 15.5 and 18.5 d.p.c. and 3, 24, and 60 days postpartum (n > 5 for
each group)
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the colon (Fig. 2b) but not the small intestine (Fig. 2c)
was shortened in the Mecp2-null mice.
Histology of distal colon samples showed that in some
areas, organization of cells of the surface seems to be al-
tered (Fig. 2d). The surface–crypt axis appeared smaller
in the Mecp2-null mice (Fig. 2d), an observation corrob-
orated by direct measurements (Fig. 2e). The number of
goblet cells (Fig. 2f ) and content of PAS-positive pixels
(Fig. 2g) was unaltered by the absence of Mecp2 in the
colon. The described alterations seemed to be age
dependent, since 4-week-old animals showed unaltered
colon and crypt length when compared to wild-type
littermates (data not shown). Histology of small intestine
appeared normal.
Colon from Mecp2-null mice showed aberrant expression
of ClC-2 and NHE-3 proteins
In order to obtain a more detailed view of the
organization of the different cell types that compose
colon epithelium, we performed immunohistochemical
detection of NKCC1 and ClC-2 membrane proteins to
differentiate and localize epithelial cells of the crypt base
and surface, respectively [9]. We observed that the
NKCC1 triple cotransporter was localized in the basolat-
eral membrane of lower and medial parts of the crypts
in both wild-type and Mecp2-null colon (Fig. 3a). ClC-2,
known to localize in the basolateral membrane of the
surface cells, was accompanied by NHE-3 detection, the
interchanger localized at the apical membrane of the
surface cells. As can be observed in Fig. 3b, distribution
of ClC-2 and NHE-3 is altered in most areas of the distal
colon of the Mecp2-null animal. ClC-2 was barely de-
tected in the basolateral membrane and was retained in
the cytoplasm of the surface cells. NHE-3 was mostly
retained at the apical membrane of surface cells, never-
theless, some cells showed intracellular staining and
NHE-3-positive staining is also observed in cells in the
entry of the crypts (Fig. 3b, right panels).
Glial-cam is an accessory protein known to interact
with ClC-2 and target the channel to cell-cell junctions
Fig. 2 Mecp2 deletion produces changes on colon morphology and histology. a Representative images of intestinal morphology (bar 1 mm).
b Summary of average colon and c small intestine length from wild-type and Mecp2-null mice.*P < 0.05 vs. wild-type (n = 6 each genotype).
d Representative images of histology H&E staining (upper) and PAS staining (lower) (bar 25 μm). e Surface–crypt axis measurements of wild-type
and Mecp2-null colon samples. *P < 0.05 vs. wild-type (n = 6 for each genotype). f PAS-positive cells and g PAS-positive pixels in wild-type and
Mecp2-null colon samples (n = 6 for each genotype)
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[12]. To determine if Glial-cam expression is altered and
could explain ClC-2 intracellular retention in Mecp2-
null colon, we determined its mRNA expression level.
Real-time PCR studies showed no differences in Glial--
cam mRNA expression between wild-type and Mecp2-
null colon (data not shown). Thus, increased intracellu-
lar localization of ClC-2 is not associated to changes in
Glial-cam mRNA expression.
Ussing chamber measurements showed no differences in
absorption and secretion in Mecp2-null mice colon
To determine if the observed cellular alterations in
Mecp2-null mice impacts electrogenic absorption and
secretion of ions in colon, we performed Ussing
chamber measurements of the colon tissues dissected
from wild-type and Mecp2-null mice. We observed no
Fig. 3 Comparison of NKCC1, ClC-2, and NHE-3 distribution in
mouse colon. a Immunoperoxidase labeling for NKCC1 in the distal
colon of wild-type (left panels) and Mecp2-null (right panels) animals.
b Double immunoperoxidase labeling for ClC-2 (blue arrows) and
NHE-3 (red arrows) in distal colon samples. Representative images of
samples taken from five mice of each genotype. Bars A and B upper
25 μm and A and B lower 10 μm
Fig. 4 Recorded Vte traces of a wild-type and b Mecp2-null colon
samples. c summarizes equivalent Isc calculation for amiloride-sensitive
sodium absorption, cAMP-dependent anionic secretion (IBMX + FSK-in-
duced) and calcium-activated anionic secretion (carbachol-induced).
n = 5 for each group
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differences in basal electrical parameters between both
genotypes obtained from experiments like those shown
in Fig. 4a, b. Calculated values were as follows: Vte −3.7
± 1.2 v/s −5.8 ± 1.2; Isc −63 ± 13 v/s −64 ± 16, and Rte 75
± 8 v/s 63 ± 4 for wild-type and Mecp2-null mice,
respectively. Calculation of short-circuit currents for
electrogenic cAMP-dependent (IBMX + FSK-induced)
or calcium-dependent (carbachol-induced) chloride se-
cretion showed no significant differences among groups.
A slight increase in electrogenic sodium absorption
(amiloride-sensitive) was observed in the Mecp2-null
colon (summarized in Fig. 4c), and without affecting sys-
temic sodium homeostasis (149 ± 3 mM v/s 148 ± 4 mM
sodium in plasma for wild-type (n = 5) and Mecp2 null
(n = 3), respectively).
Conditional deletion of Mecp2 from intestinal tissue does
not reproduce the Mecp2-null mouse phenotype
To study if Mecp2 silencing in intestinal epithelium was
able to reproduce the phenotype observed in Mecp2-null
mice, transgenic animals expressing Cre recombinase
under the control of the Villin promoter (Vil-cre) were
crossed with Mecp2flox/y female mice to induce the dele-
tion of loxP-flanked exon 3 and 4 of Mecp2. Silencing of
Mecp2 from colon epithelium was checked by immuno
detection (Additional file 1: Fig S1). As shown in Fig. 5a,
the Mecp2Δ3–4/Y mice presented significantly reduced le-
thality compared to Mecp2-null animals. Analysis of in-
testinal tissues showed that the lengths of the colon
(Fig. 5b) and small intestine (data not shown) were not
altered, nor the colon crypt length (Fig. 5c) in the Mecp2
Δ3–4/Y mice.
Shortening of colon and surface–crypt lengths are nor-
mally related to the changes in the proliferation rate of
intestinal cells. We studied the expression of Ki-67 in
colon samples and observed that Mecp2-null colon
exhibited a larger number of Ki-67-positive cells than
control tissues. Samples of Mecp2 Δ3–4/Y colon showed a
number of Ki-67-positive cells comparable to those of
control tissues (Fig. 6b). In all cases, Ki-67-positive cells
were situated at the crypt base (Fig. 6a).
Discussion
Rett syndrome is a genetic disorder that severely affects
normal development of the CNS. Nevertheless, there is
evidence for symptoms affecting peripheral tissues, and
the efforts to understand the impact of MECP2 muta-
tions in the function of other systems in the organism
have recently led to more detailed descriptions of pheno-
types affecting the respiratory, cardiovascular, and
immune systems [4, 6, 13, 14]. Symptoms affecting the
gastrointestinal tract of RTT patients are common, but
how the absence of MECP2 impacts intestinal function
is currently unknown. We observed that Mecp2 mRNA
expression in the colon decreases after birth and
increases after weaning on day 21 up to day 60, mimick-
ing what has been observed in the brain [15]. It has been
reported that the major Mecp2 isoform expressed in the
postnatal brain is Mecp2-E1 [16]; however, our analysis
showed that the main isoform expressed in colon tissue
of adult animals corresponds to Mecp2-E2. Even though
some functional differences among isoforms have been
proposed, this has been partially examined in neurons
exclusively where the absence of Mecp2-E2 protects
cultured cerebellar granule neurons from neurotoxicity
[17], but nothing is known about what is the impact of
the isoform deletion in other tissues since Mecp2-E2
silencing compromises embryo viability [18].
Examining Mecp2 distribution in intestinal tissues of
adult mice revealed some differences between immuno-
fluorescence (colon epithelial cells exclusively) and
western blot (colon epithelium and, occasionally, smooth
muscles from the colon and small intestine). The stron-
gest signal observed by western blot was detected in
Fig. 5 Intestinal deletion of Mecp2 does not replicate Mecp2-null intestinal phenotype. a A group of 14 Mecp2-null animals (solid line) was
compared with a group of 11 Mecp2Δ3–4/y conditional knock-out mice (dashed line). Kolmogorov–Smirnov test demonstrated a better survival rate
for the conditional knock-out animals over the Mecp2-null mice, P < 0.0005. Determinations of b colon length and c surface–crypt axis length
showed no differences among groups (n = 5 for wild-type, n = 9 for Mecp2Δ3–4/y, n = 4 for Mecp2flox/y, and n = 6 for Vil-Cre)
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colon epithelium correlating with the immunofluores-
cence localization. The faint signal might be due to
contamination of smooth muscle samples with epithelial
cells after mechanical stripping, or the presence of
Mecp2 expressing cell types like those of the enteric
nervous system or macrophages that can be present in
the smooth muscle layer [4, 19]. MECP2 expression in
the intestine has been previously documented in human,
rat, and mouse tissues, and the different results obtained
might reflect not only species differences but also hand-
ling of samples and heterogeneity of technics used for
MECP2 detection. For example, western blot analysis of
adult mouse tissues showed Mecp2 expression in the
colon [20], and the same authors detected northern blot
signal for Mecp2 in the colon but not in the small intes-
tine from humans. Nevertheless, expression of Mecp2
mRNA has been detected in epithelial cells of the small
intestine of adult rats [21], and other immunodetection
studies of MECP2 distribution determined that the pro-
tein is expressed in the smooth muscle [22] and in cells
of the enteric nervous system of the mouse intestine
[19]. Our immunofluorescence experiments showed no
signal for MECP2 on the smooth muscle layer. We
tested the specificity of the antibody in the colon tissue
from the Mecp2-null mouse and no signal was detected
in both the mucosa and smooth muscle.
Morphological analysis of the intestine showed a
significant reduction of the colon and crypt length in
Mecp2-null mice. Colon and crypt shortening has been
observed in animal models of colitis and inflammatory
bowel disease, as well as in mice when dyslipidemia was
induced with a high-fat diet [23–26]. Dyslipidemia has
been observed in the Mecp2−/− animals and in a signifi-
cant number of Rett patients [27]. Interestingly, Mecp2
−/− animals subjected to pharmacotherapy to improve
lipid metabolism showed amelioration of motor symp-
toms and decreased lethality [28], but the possibility that
the pharmacological restoration of lipid homeostasis is
capable to ameliorate the intestinal phenotype in the
Mecp2−/− animals has not been explored.
Our results indicate that MECP2 is expressed in colon
epithelial cells, and more specifically in the lower section
of the crypts where the stem cell niche and cells with
fluid secretion capacity are housed. We observed that
absence of MECP2 produces shortening of surface–crypt
axis lengths. Nevertheless, we observed histological
changes in cells from the surface and not in the crypt
where Mecp2 was localized. In fact, the localization and
distribution of a main membrane component of electro-
lyte movement in the colon, the triple cotransporter
NKCC1, appears to be normal in cells of the crypt in
Mecp2−/− colon. The latter observation is supported by
Ussing chamber experiments that showed intact electro-
genic anionic secretion in these animals. The Mecp2-null
mouse showed aberrant expression of membrane pro-
teins such as the chloride channel ClC-2 and the so-
dium–proton exchanger NHE3 both located in cells at
the crypt surface and major players of electroneutral
absorption of electrolytes in the colon. As we have previ-
ously demonstrated, the absence of ClC-2 produces a
severe reduction of NaCl absorption [29], and Scl9a3−/−
(Nhe3-null) mice presented with slight diarrhea due to
reduced sodium absorption in the colon [30]. Moreover,
increased electrogenic sodium absorption via ENaC has
been described in both Clc2−/− and Scl9a3−/− mouse
colon as a compensatory mechanism for reduced elec-
trolyte absorption. Our own examination of electrogenic
movement of electrolytes in colon showed a tendency to
increase amiloride-sensitive currents (reflecting ENaC-
dependent sodium absorption) in the Mecp2-null colon
that did not reached statistical significance, but that
might reflect defective electroneutral NaCl absorption.
Nevertheless, plasmatic sodium is unaffected indicating
that sodium homeostasis is normal in the Mecp2-null
mice and that the intestinal malfunction might be trig-
gered at a very late stage of the disease and for a short
Fig. 6 Ki-67-positive cells are increased in the Mecp2-null animals. a Representative images of Ki-67 immunodetection in colon samples (bar 25 μm).
b Summary of Ki-67-positive cells per crypt for wild-type 8 weeks old (n = 3), Mecp2-null 8 weeks old (n = 3), wild-type 16 weeks old (n = 5), and
Mecp2Δ3–4/y 16 weeks old (n = 4). *P < 0.03 compared to wild-type 8 weeks old
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period of time that is not long enough to reflect sodium
reduction in the circulation. It is also important to com-
ment that a significantly increased intestinal transit time
has been recently reported to occur in the Mecp2-null
mice and that could also favor malabsorption and the
appearance of watery stools observed by us in the
Mecp2-null animals [31].
After we described the effects of MECP2 absence in
the colon, we questioned if using the Cre-loxP system
the sole deletion of Mecp2 from intestinal epithelium
was sufficient to reproduce the intestinal phenotype of
the Mecp2-null mouse. We first observed that intestinal
deletion of Mecp2 did not bear a lethal phenotype and,
most surprisingly, it did not reproduce the colon and
surface–crypt axis length changes as the Mecp2-null
mouse. Such absence of changes in colon morphology
and histology was sustained up to 16 weeks of life.
We observed an increase of the proliferation marker
protein Ki-67 in colon epithelial cells of Mecp2-null ani-
mals, a similar finding that has been reported in colitis
models involving mice [32, 33]. Even though cells ex-
pressing Ki-67 expression are found at the same location
where we detected MECP2 in the cells of the lower part
of the colon crypts, the exclusive silencing of Mecp2
from the intestine does not increase the number of Ki-
67-positive cells, suggesting that Rett phenotype in colon
can be originated by factors released outside the colon
or by altered activity of cells other than colonic epithe-
lium like the enteric nervous system where MECP2 is
expressed [31]. Other explanation might be that cells in
the surface can be affected by alterations in the intestinal
contents delivered from the small intestine into the
colon. For example, bile acids are known to induce col-
itis in mice and humans [34, 35], and even when there is
no available data for fecal bile acid contents in RTT pa-
tients or animal models, scattered reports of RTT pa-
tients hospitalized due to liver failure and many others
subjected to gallbladder removal are available [27]. More
recently, it has been published that Rett patients
presented with a less diverse microbiota than healthy
subjects [36], which could affect gastrointestinal func-
tion, but this possibility has not been explored in the
mouse model yet.
Conclusions
In summary, we have described for the first time the ef-
fects of Mecp2 silencing on mouse intestine. Our results
indicate that the absence of Mecp2 induces shortening
of the colon length and depth of crypts. Along with
histological changes in the cells at the surface of the
colon and mislocalization of key membrane proteins
responsible for electroneutral fluid absorption, this
might favor fluid accumulation often seen in the Mecp2-
null mice. Importantly, the sole silencing of Mecp2 from
intestinal epithelium did not account for the complete
phenotype, suggesting the participation of other cells
that express MECP2 and regulate intestinal function as
well as and the profound complexity of this disease.
Additional file
Additional file 1: Figure S1. Intestinal MECP2 deletion using the villin-Cre
Tg mouse. Immunofluorescence was performed to detect MECP2 protein in
colon samples from (A) Mecp2flox/y mouse and (B) Mecp2Δ3–4/y. Positive signal
was detected in the Mecp2Δ3–4/y mouse at the bottom of the crypts mainly.
Representative images of three animals per group. (DOCX 211 kb)
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